NGNE
Neurogene Inc
31.30$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -0.4% | -1.0% | -1.2% | -1.1% | -4.5% | +0.7% | +5.9% | -3.1% | +8.5% | -4.0% | – | |
| – | -8.0% | +194.4% | +121.4% | +6.9% | +0.5% | +62.8% | -15.8% | -1.3% | -0.1% | +7.9% | +116.6% | – | |
| – | -22.0% | -631.7% | – | – | -135.0% | – | – | – | – | -65.5% | +85.9% | – | |
| – | +186.9% | -72.4% | +607.7% | -63.7% | -30.5% | +572.4% | -81.0% | -14.8% | -9.4% | +145.9% | +26.0% | – | |
| – | – | +79.4% | -178.9% | +22.7% | +254.3% | -56.1% | – | +201.2% | +33.2% | +54.8% | -86.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +8.3% | +15.4% | -6.7% | -7.1% | +46.2% | -68.4% | -16.7% | – | |
| – | – | -107.1% | – | -67.2% | +144,987.8% | -100.0% | +1,250.0% | +18,154.8% | +108.7% | -99.1% | +2,967.2% | – | |
| – | – | -98.6% | -2,320.8% | – | – | -194.1% | – | – | +169.4% | -38.1% | -157.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.